Zura Bio Relocates HQ to Henderson, NV; Updates Contact Info

TL;DR

**Zura Bio moved its HQ to Henderson, NV, and changed its phone number.**

AI Summary

Zura Bio Ltd. filed an 8-K on January 3, 2024, to update its principal executive offices to 1489 W. Warm Springs Rd. #110, Henderson, Nevada 89014, from its previous La Jolla, CA address. This administrative change also updated their business phone number to (702) 757-6133. For investors, this matters because it signals a potential operational relocation or consolidation, which could impact overhead costs or strategic focus, though the filing itself doesn't detail the 'why' behind the move.

Why It Matters

This filing indicates a change in Zura Bio's physical headquarters and contact information, which could reflect operational shifts or cost-saving measures, potentially impacting future business efficiency.

Risk Assessment

Risk Level: low — This filing is purely administrative, reporting a change of address and contact information, which carries minimal direct risk to investors.

Analyst Insight

Investors should note the administrative change of address and contact information, but this filing alone does not warrant immediate action. It would be prudent to monitor future filings for any strategic reasons behind the relocation.

Key Numbers

• $0.0001 — Par value per share (par value of Zura Bio's Class A Ordinary Shares)

Key Players & Entities

• Zura Bio Ltd (company) — the registrant filing the 8-K
• 1489 W. Warm Springs Rd. #110 Henderson , Nevada 89014 (address) — new principal executive offices
• (702) 757-6133 (phone_number) — new business phone number
• 4225 EXECUTIVE SQUARE SUITE 600 LA JOLLA CA 92037 (address) — former business address
• $0.0001 (dollar_amount) — par value per Class A Ordinary Share

Forward-Looking Statements

• Zura Bio Ltd. will continue to operate from its new Henderson, Nevada headquarters. (Zura Bio Ltd.) — high confidence, target: 2025-01-03

FAQ

Key Financial Figures

• $0.0001 — ed Class A Ordinary Shares, par value $0.0001 per share ZURA The Nasdaq Stock Mar
• $11.50 — Ordinary Share at an exercise price of $11.50 per share ZURAW The Nasdaq Stock Ma

Filing Documents

• tm241521d1_8k.htm (8-K) — 27KB
• tm241521d1_ex99-1.htm (EX-99.1) — 11KB
• tm241521d1_ex99-1img01.jpg (GRAPHIC) — 8KB
• 0001104659-24-000494.txt ( ) — 269KB
• zura-20240102.xsd (EX-101.SCH) — 3KB
• zura-20240102_def.xml (EX-101.DEF) — 26KB
• zura-20240102_lab.xml (EX-101.LAB) — 36KB
• zura-20240102_pre.xml (EX-101.PRE) — 25KB
• tm241521d1_8k_htm.xml (XML) — 5KB

01

Item 7.01. Regulation FD Disclosure. On January 3, 2024, Zura Bio Limited issued the press release attached hereto as Exhibit 99.1 to this Current Report on Form 8-K. The information set forth in this Item 7.01 is intended to be furnished and shall not be deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the " Exchange Act "), or otherwise 1933, as amended, or the Exchange Act, except as expressly set forth by specific reference in such filing.

Financial Statements and Exhibits

Financial Statements and Exhibits. (d) Exhibits Exhibit No. Description 99.1 Press Release dated January 3, 2024. 104 Cover Page Interactive Data File (embedded within the Inline XBRL document).

SIGNATURES

SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934 the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. Date: January 3, 2024 ZURA BIO LIMITED By: /s/ Kim Davis Kim Davis Chief Legal Officer

View Full Filing

View this 8-K filing on SEC EDGAR